Abstract
We report on the combined use of endogenous two-photon intensity and lifetime based fluorescence measurements to identify changes in specific metabolic pathways. Such functional insights can improve understanding of disease development and drug effects.
© 2018 The Author(s)
PDF ArticleMore Like This
Irene Georgakoudi
FF5A.2 Frontiers in Optics (FiO) 2016
Joanna Xylas, Margaret McLaughlin-Drubin, Karl Munger, and Irene Georgakoudi
BSu3A.33 Biomedical Optics (BIOMED) 2012
Zhiyi Liu, Eugen Dhimolea, Antonio Varone, Constantine S. Mitsiades, and Irene Georgakoudi
OmM4D.2 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2017